- 米国企業
- Synaptogenix, Inc.
Synaptogenix, Inc.SNPX
時価総額
$6057.9万
PER
2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Cash and cash equivalents | 6 | 34 | 38 |
Prepaid Clinical trial expenses | - | 1 | 367,714 |
Prepaid expenses and other current assets | 806,289 | 18,689 | 739,467 |
TOTAL CURRENT ASSETS | 7 | 36 | 39 |
Property, Plant and Equipment, Net | 22,212 | 20,445 | 22,145 |
TOTAL ASSETS | 7 | 36 | 39 |
Accounts payable | 1 | 1 | 660,206 |
Accrued expenses | 352,154 | 698,406 | 536,714 |
Dividend payable | - | - | 115,890 |
TOTAL CURRENT LIABILITIES | 2 | 2 | 1 |
Warrant liability | - | - | 2 |
Derivative liability | - | - | 370,300 |
TOTAL LIABILITIES | - | - | 3 |
Temporary Equity, Carrying Amount, Attributable to Parent | - | - | 3 |
Common Stock, Value, Issued | 503 | 674 | 728 |
Additional paid-in capital | 7 | 48 | 53 |
Accumulated deficit | -1,530,473 | -14,141,670 | -19,831,517 |
TOTAL STOCKHOLDERS' EQUITY | 5 | 34 | 33 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | 7 | 36 | 39 |